Current Ratio of ACADIA PHARMACEUTICALS INC from 31 Mar 2012 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
ACADIA PHARMACEUTICALS INC quarterly Current Ratio in x history and change rate from 31 Mar 2012 to 31 Dec 2025.
- ACADIA PHARMACEUTICALS INC Current Ratio for the quarter ending 31 Dec 2025 was 3.14x, a 41% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
ACADIA PHARMACEUTICALS INC Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 3.14x | +0.91x | +41% | 31 Dec 2025 |
| Q3 2025 | 2.78x | +0.56x | +25% | 30 Sep 2025 |
| Q2 2025 | 2.59x | +0.37x | +17% | 30 Jun 2025 |
| Q1 2025 | 2.41x | +0.09x | +3.8% | 31 Mar 2025 |
| Q4 2024 | 2.22x | -0.18x | -7.7% | 31 Dec 2024 |
| Q3 2024 | 2.22x | -0.46x | -17% | 30 Sep 2024 |
| Q2 2024 | 2.23x | -0.87x | -28% | 30 Jun 2024 |
| Q1 2024 | 2.32x | -1.21x | -34% | 31 Mar 2024 |
| Q4 2023 | 2.41x | -1.98x | -45% | 31 Dec 2023 |
| Q3 2023 | 2.68x | -2.24x | -46% | 30 Sep 2023 |
| Q2 2023 | 3.09x | -2.44x | -44% | 30 Jun 2023 |
| Q1 2023 | 3.53x | -2.59x | -42% | 31 Mar 2023 |
| Q4 2022 | 4.39x | -2.24x | -34% | 31 Dec 2022 |
| Q3 2022 | 4.92x | -1.79x | -27% | 30 Sep 2022 |
| Q2 2022 | 5.54x | -1.34x | -19% | 30 Jun 2022 |
| Q1 2022 | 6.13x | -1.13x | -16% | 31 Mar 2022 |
| Q4 2021 | 6.63x | -0.94x | -12% | 31 Dec 2021 |
| Q3 2021 | 6.71x | -1.65x | -20% | 30 Sep 2021 |
| Q2 2021 | 6.88x | -2.14x | -24% | 30 Jun 2021 |
| Q1 2021 | 7.26x | -1.44x | -17% | 31 Mar 2021 |
| Q4 2020 | 7.57x | -1.01x | -12% | 31 Dec 2020 |
| Q3 2020 | 8.36x | +0.16x | +2% | 30 Sep 2020 |
| Q2 2020 | 9.01x | +1.96x | +28% | 30 Jun 2020 |
| Q1 2020 | 8.7x | +1.8x | +26% | 31 Mar 2020 |
| Q4 2019 | 8.59x | +1.36x | +19% | 31 Dec 2019 |
| Q3 2019 | 8.2x | +1.38x | +20% | 30 Sep 2019 |
| Q2 2019 | 7.05x | -0.8x | -10% | 30 Jun 2019 |
| Q1 2019 | 6.91x | -2.15x | -24% | 31 Mar 2019 |
| Q4 2018 | 7.23x | -2.75x | -28% | 31 Dec 2018 |
| Q3 2018 | 6.82x | -4.6x | -40% | 30 Sep 2018 |
| Q2 2018 | 7.85x | -4.57x | -37% | 30 Jun 2018 |
| Q1 2018 | 9.06x | -4.18x | -32% | 31 Mar 2018 |
| Q4 2017 | 9.97x | -5.48x | -35% | 31 Dec 2017 |
| Q3 2017 | 11.42x | -3.95x | -26% | 30 Sep 2017 |
| Q2 2017 | 12.42x | -2.6x | -17% | 30 Jun 2017 |
| Q1 2017 | 13.24x | -1.71x | -11% | 31 Mar 2017 |
| Q4 2016 | 15.45x | +1.77x | +13% | 31 Dec 2016 |
| Q3 2016 | 15.37x | -1.02x | -6.2% | 30 Sep 2016 |
| Q2 2016 | 15.02x | -4.61x | -24% | 30 Jun 2016 |
| Q1 2016 | 14.94x | -10.01x | -40% | 31 Mar 2016 |
| Q4 2015 | 13.68x | -17.75x | -56% | 31 Dec 2015 |
| Q3 2015 | 16.39x | -19.03x | -54% | 30 Sep 2015 |
| Q2 2015 | 19.63x | -15.09x | -43% | 30 Jun 2015 |
| Q1 2015 | 24.95x | -6.58x | -21% | 31 Mar 2015 |
| Q4 2014 | 31.43x | +6.83x | +28% | 31 Dec 2014 |
| Q3 2014 | 35.42x | +12.81x | +57% | 30 Sep 2014 |
| Q2 2014 | 34.72x | +17.39x | +100% | 30 Jun 2014 |
| Q1 2014 | 31.53x | +21.03x | +200% | 31 Mar 2014 |
| Q4 2013 | 24.6x | +17.45x | +244% | 31 Dec 2013 |
| Q3 2013 | 22.61x | +18.53x | +454% | 30 Sep 2013 |
| Q2 2013 | 17.33x | +12.79x | +282% | 30 Jun 2013 |
| Q1 2013 | 10.49x | +5.04x | +92% | 31 Mar 2013 |
| Q4 2012 | 7.15x | 31 Dec 2012 | ||
| Q3 2012 | 4.08x | 30 Sep 2012 | ||
| Q2 2012 | 4.54x | 30 Jun 2012 | ||
| Q1 2012 | 5.45x | 31 Mar 2012 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.